# Selegiline Patch for Treatment of Nicotine Dependence

> **NCT01330030** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 243 (actual)

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DRUG:** Selegiline
- **OTHER:** matching placebo

## Key facts

- **NCT ID:** NCT01330030
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-08
- **Final completion:** 2011-07
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2016-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01330030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01330030, "Selegiline Patch for Treatment of Nicotine Dependence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01330030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*